Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

Novo Nordisk's hopes of heralding a new era of obesity ... could provide further color on the drug's efficacy over an extended duration and more flexible dosing — something Lontoft said could ...

Viking Therapeutics seems to be doubling down on its hopes of making waves in the weight management market as a stand-alone ...